Martin Edwards, Ph.D.
Martin Edwards is a Senior Partner at Novo Ventures, the venture capital arm of Novo A/S. Previously, Dr. Edwards was Chief Executive Officer of ReNeuron Ltd. taking the company public in 2001. He served as Global Head of Drug Development for Novo Nordisk, Senior Vice President at Novo Nordisk (USA), and Chief Medical Officer/Vice President at Zymogenetics. Dr. Edwards trained in physiology and medicine in Manchester, UK and in business at Warwick University. In 2009, Dr. Edwards was made Adjunct Professor at CBS SIMI in Copenhagen.